Johnson & Johnson (JNJ) Q4 2025 Earnings Call Transcript
Johnson & Johnson (NYSE: JNJ) Q4 2025 Earnings Call dated Jan. 21, 2026 Corporate Participants: Darren Snellgrove — Vice President of Investor Relations Joaquin Duato — Chairman and Chief Executive Officer Joe Wolk — Chief Financial Officer Tim Schmid — Executive Vice President and Worldwide Chairman of MedTech John Reed — Executive Vice President, Innovative […]
Johnson & Johnson (JNJ) Q4 2025 Earnings Call Transcript Read More »